foxo4-dri senolytic human trial Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells Buy FOXO4-DRI Peptide (Proxofim) -
Buy FOXO4 DRI Peptide (Proxofim) 10mg BiotechPeptides Tools to eliminate senescent cells Nature Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment npj Aging Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv
Pay in 4 interest-free payments of $5.42 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 13 - Oct 18




